Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
Abstract Background In the Response Evaluation Criteria for Solid Tumors (RECIST) diagnostic criteria, the concepts of progression by preexisting disease (PPL) and progression by new metastases (PNM) have been proposed to distinguish between the progression types of cancer refractory to treatment. A...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2021-11-01
|
| Series: | World Journal of Surgical Oncology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12957-021-02441-w |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|